Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin.

Completed · Phase 2

Conditions studied: Metastatic Breast Cancer, Neoplasms, Breast

In brief

The purpose of this study is to determine the efficacy of an oral investigational drug for the treatment of metastatic breast cancer tumors that are known to overexpress HER2/neu.

Key facts

Study ID

NCT00051103

Run by

GlaxoSmithKline

Starts

2002-10-01

Expected to finish

2005-06-01

Last updated by the study team

2015-04-15

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• GSK Investigational Site — Chula Vista, California, United States
• GSK Investigational Site — Los Angeles, California, United States
• GSK Investigational Site — Poway, California, United States
• GSK Investigational Site — Fort Myers, Florida, United States
• GSK Investigational Site — Plantation, Florida, United States
• GSK Investigational Site — Savannah, Georgia, United States
• GSK Investigational Site — Park Ridge, Illinois, United States
• GSK Investigational Site — Skokie, Illinois, United States
• GSK Investigational Site — Skokie, Illinois, United States
• GSK Investigational Site — Bettendorf, Iowa, United States
• GSK Investigational Site — Des Moines, Iowa, United States
• GSK Investigational Site — Baltimore, Maryland, United States
• GSK Investigational Site — Royal Oak, Michigan, United States
• GSK Investigational Site — Billings, Montana, United States
• GSK Investigational Site — Hooksett, New Hampshire, United States
• GSK Investigational Site — Durham, North Carolina, United States
• GSK Investigational Site — Greenville, North Carolina, United States
• GSK Investigational Site — Hickory, North Carolina, United States
• GSK Investigational Site — Fargo, North Dakota, United States
• GSK Investigational Site — Oklahoma City, Oklahoma, United States
• GSK Investigational Site — Tulsa, Oklahoma, United States
• GSK Investigational Site — Pittsburgh, Pennsylvania, United States
• GSK Investigational Site — Columbia, South Carolina, United States
• GSK Investigational Site — Germantown, Tennessee, United States
• GSK Investigational Site — Memphis, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.